Great article, thanks. So much in this sounds just
Post# of 72440
Here's where CTIX is different -- what was true for PCYC is NOT true for CTIX which has three promising drugs in its pipeline, for 4 different applications (so far).
PCYC:
Quote:
Like many small biotech companies, it had staked all its hopes and resources on this one product.
It was so fortunate that their cheap-purchase drug worked -- otherwise it would have been just another failed small biotech. Instead, their junk-heap purchase is saving lives and made fortunes.